Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (391-400 of 611) with videos related to

Pageof 62
Sort By:
Free Radical Biology & Medicine|December 9, 2009
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stressStefano Lancellotti, Vincenzo De Filippis, Nicola Pozzi, et al.
Blood Advances|March 26, 2024
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxisSara Arcudi, Roberta Gualtierotti, Erica Scalambrino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 16, 2020
Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiencyClaudia Djambas Khayat, Sunil Lohade, Fulton D'Souza, et al.
Thrombosis and Haemostasis|June 11, 2025
Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in FranceClaire Auditeau, Carla Valsecchi, Nûn Kalim Bentounes, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2020
Complement activation in patients with COVID-19: A novel therapeutic targetMassimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
Acta Chirurgica Iugoslavica|March 28, 2014
Clinical experience in treatment of thrombotic thrombocytopenic purpura--hemolytic uremic syndrome with 28 patientsDragica Vuclić, Zoran Rajić, Nebojsa Savić, et al.
Srpski Arhiv Za Celokupno Lekarstvo|October 1, 2013
Diagnostic relevance of ADAMTS13 activity: evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosisDragica Vucelić, Danijela Miković, Zoran Rajić, et al.
Blood|February 3, 2023
Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 studyLynn Malec, An Van Damme, Anthony K C Chan, et al.
European Journal of Haematology|October 22, 2024
Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE StudyJohannes Oldenburg, Charles Hay, Flora Peyvandi, et al.
Haematologica|July 15, 2021
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaSara Bonato, Andrea Artoni, Anna Lecchi, et al.
Pageof 62

Showing results (391-400 of 611) with videos related to

Sort By:
Pageof 62
Free Radical Biology & Medicine|December 9, 2009
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stressStefano Lancellotti, Vincenzo De Filippis, Nicola Pozzi, et al.
Blood Advances|March 26, 2024
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxisSara Arcudi, Roberta Gualtierotti, Erica Scalambrino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 16, 2020
Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiencyClaudia Djambas Khayat, Sunil Lohade, Fulton D'Souza, et al.
Thrombosis and Haemostasis|June 11, 2025
Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in FranceClaire Auditeau, Carla Valsecchi, Nûn Kalim Bentounes, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2020
Complement activation in patients with COVID-19: A novel therapeutic targetMassimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
Acta Chirurgica Iugoslavica|March 28, 2014
Clinical experience in treatment of thrombotic thrombocytopenic purpura--hemolytic uremic syndrome with 28 patientsDragica Vuclić, Zoran Rajić, Nebojsa Savić, et al.
Srpski Arhiv Za Celokupno Lekarstvo|October 1, 2013
Diagnostic relevance of ADAMTS13 activity: evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosisDragica Vucelić, Danijela Miković, Zoran Rajić, et al.
Blood|February 3, 2023
Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 studyLynn Malec, An Van Damme, Anthony K C Chan, et al.
European Journal of Haematology|October 22, 2024
Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE StudyJohannes Oldenburg, Charles Hay, Flora Peyvandi, et al.
Haematologica|July 15, 2021
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaSara Bonato, Andrea Artoni, Anna Lecchi, et al.
Pageof 62